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You may well wonder why I have combined a
talk on diabetes in children and adolescents with one
on diabetic microangiopathy when as pediatricians
we rarely, if ever, see clinical evidence of the sequelae
of vascular disease in our patients. If we see proteinuria in a child, we seek another cause. We may see
young teen-agers with a microaneurysm or a trace of
protein, but we soon refer them to our internist
friends who fall heir to the care of problems that
doubtless have their beginning in childhood years .
Pediatricians are, therefore, concerned about these
problems and the adequacy of treatment they are
prescribing for their young diabetic patients.
There is a recent movement to place considerable emphasis again on strict control of blood glucose as a means of reducing complications of diabetes. In an effort to achieve better control rnany
physicians are placing their patie11ts on two injections
a day.
I believe we can say that there are few, if any,
physici ans today who could duplicate Dr. Elliott P.
Joslin's success in obtaining patient cooperation in
his efforts to control their diabetes. Yet data from his
clinic show that only a small percentage achieved
what he considered excellent control. Nqr did we see
a striking difference in the incidence of complications
in his patients when compared with that in the general diabetic population.
I do not minimize the need for achieving as
nearly optimal control as one can with insulin , but I
believe a return to the old emphasis on strict control
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does a disservice to our diabetic children and adolescents . It misleads them into thinking that controlling
the blood sugar adequately is possible with present
day methods of insulin administration; that if this is
achieved, it will prevent or slow down complications;
and that if this is not achieved, even with the most
conscientious efforts, it is the patient's fault. I believe
there is evidence that none of the above is true. A )so,
this re-emphasis on <;.:ontrol and what it does or does
not do to the basement membrane, diverts our attention from pursuing other productive avenues of research that may uncover clues and therapeutic approaches. It is with some of these avenues that I
would like to acquaint you and stir your interest.
I would like first to address myself to important
considerations in the care of the child or adolescent
who has diabetes .
It is , of course, fundamental that the patient and
the parents be properly educated about diabetes and
its control at the very beginning if one is to expect
acceptance and participation in a program of good
management. We feel this should always be initiated
on a hospital ward even if the child is not acidotic.
Here the patient and parents can work with a teaching team in a relaxed setting where questions can
readily be answered before the family is left on its
own . The focus of instruction for the very young
child a nd infant is both parents; by 7 to 10 years of
age the child can help with urine testing; the 11-yearold can learn to give his or her own injections. In the
teens the patient becomes the focus of instruction
with parents also learning the facts and techniques.
Do not be misled on this point: teen-agers very much
need and want the support of their parents in these
circumstances.
As soon as the patient has intravenous feedings
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discontinued and is ambulatory the routine that he or
she will continue at home is initiated. After the acidosis is cleared the patient is not awakened during the
night hours for either urine testing or supplemental
insulin.
The educational process continues upon discharge from the hospital, first with phone calls to talk
over changes in insulin dosage, and then in weekly
visits to the clinic. As confidence and understanding
increase, visits are less frequent but are continued
with regularity.
What do we teach our patients about diabetes
and how it should be managed?
Good management of the diabetic begins with
the physician's smooth management of the initial ketoacidotic episode, for actions speak louder than
words. I believe pediatricians have an advantage here
because it can be said with certainty, if not with
modesty, that pediatricians have been in the forefront
in the proper administration of fluids and electrolytes.
One need only recall the names of Gamble, Butler,
and Darrow to know that we have had good mentors.
Fluids play a most important role in recovery from
acidosis; no amount of insulin will rid the patient of
the accumulation of hydrogen ion and restore his or
her base deficit. Briefly, the initial hydrating solution
is a mildly hypotonic solution of sodium chloride free
of potassium, containing bicarbonate if acidosis warrants its use. This is followed by a more hypotonic
solution including potassium and dextrose, usually
around the second hour. We discourage the use of
isotonic saline as unphysiologic because of its high
anion concentration and the absence of free water.
Pediatricians also for many years have been administering small doses of insulin at frequent intervals
instead of the large doses prescribed in adults. Indeed, the recent introduction of continuous intravenous administration of low levels of insulin has
little if any advantage over our long-used methods of
administration. We begin with 0.5 to 1.0 units/ kg
crystalline insulin, giving half intravenously and half
deep subcutaneously, Every hour the dose is reduced
by 50% unless the interval reveals no progress in
reducing the blood glucose. The previous hour' s dose
is then repeated.
After intravenous therapy is discontinued and
oral feedings initiated, regular insulin is given with
meals for one or two days. Lente®, a long-acting
insulin, comprised of 70% Ultralente® and of 30%
Semilente®, is then given once daily prior to breakfast.
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Our goal is to allow a trace or 1 + glycosuria in
urines tested prior to meals and at bedtime. The
Lente® is increased daily by 2 to 4 units until control
is achieved.
We teach the patient to monitor his or her diabetic control through daily urine tests: that is, a
double-voided specimen before breakfast, before supper, and at bedtime. After discharge from the hospital we allow time for a pattern to develop in response
to the child's home and school routine. If the glycosuria falls to negative levels after discharge as so
frequently happens, the patient reduces the Lente®
Insulin by 2 units after a day of negative tests, or by 4
units if there are symptoms as well. If glycosuria
increases uniformly before breakfast and before supper, the patient increases it by 2 units every three to
four days until control is again achieved. If a pattern
of glycosuria develops in which all the morning
urines are 3 + to 4 + and the pre-supper urines are O
to 1+, the patient increases the Ultralente® or longacting portion of the Lente® mixture. Conversely, if
late afternoon urines are high in sugar, the patient
increases the short-acting or Semilente® portion. In
this way we achieve as good control over the 24-hour
period as with those who use NPH® twice a day and
avoid the use of two injections. For this reason we
have abandoned the use of NPH® in favor of the
Lentes®. As those of you who follow young children
know very well, there frequently is no pattern to the
glycosuria, and levels will go from negative to 4+ .
One may be guided in such circumstances by daily
urine volumes and adjust the insulin to keep urine
volumes in the normal range.
If acetone appears, the patient is to take regular
insulin at that time. He or she is asked to take 1/ 5 of
his or her daily dose of Lente® for moderate or large
and 1/ 10 for small amounts of acetone. This is repeated at subsequent testings if acetone persists.
If the child becomes ill and is unable to eat or is
vomiting, the Lente® is omitted and small amounts of
regular insulin are given. Depending on the nature of
the problem, the child will be seen in the Emergency
Room; admitted, or followed at home by phone instructions.
The diet we propose for the diabetic is no different from one we propose for the non-diabetic. It consists of a good source of protein as the cornerstone of
the diet, carbohydrate obtained mainly from
starches, a drastic reduction in refined sweets, a mixture of predominantly unsaturated and saturated
fats, and, finally , foods containing adequate rough-
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age, minerals, and vitamins. We allow the patient to
use his appetite as his guide, warning against gorging
or excessive snacks, and to use his weight-for-height
gains as a monitor of his progress. If overweight is or
becomes a problem in the diabetic, he should be
approached as a youngster, not a diabetic, with a
weight problem. I see no reason to single out the
diabetic in his diet therapy when there is no scientific
data to suggest this approach is any more harmful to
him than to his non-diabetic peers.
We do not attempt to make gross changes in a
patient's lifestyle. We recommend regular exercise for
all youngsters, but we do not urge all-out vigorous
athletics if that is not the child's habit. If exercise can
be anticipated, the morning dose of insulin is reduced. If it cannot, increased carbohydrate intake
during and after the exercise is required. We explain
to teen-agers the serious effects of smoking on the
cardiovascular system and urge them not to begin.
We explain the hazards of drinking and urge care in
this area if they do indulge.
There are a number of special problems we see in
children and adolescents.
First of all, the term "brittle" diabetic is frequently used to describe the majority of juvenile diabetics. I believe this is too broad a use of the term and
often reflects only a poor understanding of how to
manage youngsters whose exercise pattern is unpredictable and whose increased needs with growth are
not properly met. I would reserve the term for the
juvenile diabetic who is truly difficult to manage; in
my experience such patients are few in number and
all have been teen-age girls under severe emotional
stress.
In the adolescent years there is both an increase
in need for insulin and an increase in binding, with
insulin resistance of variable degree resulting. Requirements can often rise at an alarming rate to needs
of 140 to 160 units per day. The periods of increased
need are variable and unpredictable in their length .
When the total daily dose reaches 90 to I 00 units the
dosage is split; 2/ 3 is given before breakfast and I / 3
before supper. It is frequently advisable to admit the
patient to make these adjustments. We admit the
teen-ager to the Children's Rehabilitation Center
where both physical and school activities can be pursued so that home conditions are more nearly simulated than on a hospital ward. A schedule is set up in
which, again, the patient participates. Pre-meal and
two-hour post-meal blood glucoses are obtained,
urine volumes are measured, and caloric estimates of

the food intake that satisfies the patient's appetite in a
normal manner are made. Urine volumes are collected in the following manner: patient voids and
discards at 7 AM ; Urine #1 is voidings up to lunch;
urine #2 up to dinner; urine #3 up to 9 PM, and urine
#4 overnite to 7 AM. In this manner grams of glucose/ hour spilled in respect to a meal can be 1::alculated. Urine volumes collected periodically at home
give the diabetic another index of his control.
True insulin resistance is defined rather arbitrarily as a requirement that exceeds 200 units per
day, occurring in the absence of ketosis, infections, or
other known stresses. The few cases that have occurred in juvenile diabetics have been predominantly
among teen-agers 14 to 16 years of age. Most are due
to increased antibody formation and respond either
to changing to pork insulin, which is less antigenic
than beef, or to steroid therapy . We have recently
reported the very rare occurrence of severe resistance
to insulin in a 17-year-old gi'rl who does not have
excessive antibodies either to insulin or to her insulin
receptors and showed no improvement on steroids.'
She was resistant to as much as 5,000 units in pork
regular insulin given subcutaneously, but responded
normally to a continuous 24-hour infusion of insulin
and was well regulated in 60 to 70 units pet day. After
5 months of continuous I. V. insulin she remitted
spontaneously and is presently regulated on 85 units
Lente® in the morning and 35 units Lente® before
supper. Since our report, 5 more females of similar
age with the same problem have come to our attention.
Over-treatment with insulin can of course result
in hypoglycemia, but it can also result in a curious
and unexplained phenomenon called the Somogyi
reaction, which usually appears after sudden and excessive increases in insulin. The reaction is characterized by polydipsia and polyuria, sometimes to an
overwhelming degree. Unlike the patient in acidosis,
however, the C0 2 is not elevated though the glucose
values may be very high. The explanation given by
Somogyi is that the intense hypoglycemia generated
by excessive insulin, usually occurring between 2 AM
and 4 AM, causes a discharge of adrenalin and a swift
rise in blood glucose to excessive levels. The increased
glycosuria in the morning and the excessive polyuria
suggest the need for more insulin, and a vicious circle
ensues. The patient needs to be hospitalized, taken
off long-acting insulin, and regulated on regular insulin before returning to Lente®.
One final problem we encounter, especially in
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teen-agers, is noncompliance. This must be dealt with
in a sympathetic yet firm manner. One can only have
deep feelings of empathy for youths who are struggling to establish their own identity in a world generally hostile to teen-agers, and who are aware that in
the not-too-distant future they will be on their own.
Our approach,2 therefore, is to keep the demands on the patient simple but to work closely with
him to follow these simple rules:
1) Double void urine twice a day, test for glucose and acetone, and record results so they
can be reviewed with the patient.
2) Take insulin without fail each morning.
3) Eat a sound diet at regular time intervals and
in amounts that satisfy appetite and maintain
normal weight.
4) Keep regular medical appointments at 3month intervals. This provides an opportunity to review the patient's understanding of
diabetes and its control.
would now like to turn to a discussion of
abnormalities in serum proteins, platelets, and red
blood cells of diabetic subjects discussed at a conference on Diabetic Microangiopathy held by the Kroc
Foundation in April, 1976. The conference was arranged by Dr. Donald McMillan of the Sansum
Medical Research Foundation and Dr. John Ditzel
of Aalborg, Denmark, and the papers have appeared
in the November, 1976 supplement of Diabetes. 3
The abnormalities I wish to describe may play a
role in the genesis of diabetic angiopathy or are factors that reduce tissue delivery of oxygen by hemoglobin. These mechanisms can lead to tissue hypoxia
and subsequent tissue damage.
First, Dr. McMillan, 4 as well as others, describes
significant increases in serum proteins in diabetics.
No system of proteins is spared. Studies of newly
diagnosed diabetics show increases as great as those
in established diabetics. Abnormalities are independent of the presence of sequelae of microangiopathy .
The majority of the proteins elevated in diabetics
are acute phase reactants: a 1 acid glycoproteins, a1
antitrypsin, haptoglobin, ceruloplasmin, C-reactive
protein, C3C, C4 and C3 activator, and fibrinogen.
Albumin levels are lower than normal. By direct measurement Dr. McMillan has shown that diabetic serum has a greatly increased viscosity which is due to
the elevation of these proteins. The abnormal viscosity bears no relation to age, sex, body weight or
duration or type of treatment of the diabetes.
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Erythrocyte aggregation is markedly increased
due to the increased fibrinogen level as well as to
increases in other elongated proteins. Increased
erythrocyte aggregation has the added effect of enhancing the coagulation of blood.
Platelet aggregation is also increased in diabetics
in the early stages of the disease as well as later. There
is a greater sensitivity than normal to aggregating
agents such as adenosine diphosphate (ADP), epinephrine, and collagen.
At the same time that intravascular factors are
leading to the occlusion of small blood vessels, the
fibrinolytic system, the body's defense against vascular occlusion, is decreased. This abnormality is more
pronounced m patients with signs of microangiopathy.
We have recently made observations on red cell
membranes in diabetics and have noted an abnormal
adherence of hemoglobin to the red cell membranes. 5
Red cell ghosts prepared by the method of
Dodge were solubilized in 1% sodium dodecycl sulfate (SOS), separated by gel electrophoresis and
stained with Coomassie® Blue (Figure). Increased
amounts of hemoglobin were noted in the membranes of diabetics, B, C, and D, compared to those
of a non-diabetic child, A. Dislodging the hemoglobin from red cell ghosts with Tris (hydroxymethyl
aminomethane ), a nonionic buffer, simultaneously
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Figure-Membrane proteins of erythrocyte ghosts in I% SDS separated by polyacrylamide gel electrophoresis and stained with Coomassie"9 Blue. A to D (untreated ghosts): A, normal 12-year-old; B,
8-year-old on insulin one month; C, top layer of ghosts, pale yellow,
D, bottom layer, pink , 15-year-old on insulin five years. E and F
(ghosts extracted with 0.01 M Tris, pH 8.2): E - A; F - B.G to J
(Tris eluates): G - A, H - C, I - D, and J - B. In D note the
doublet of band 6 and the heavy band of hemoglobin, and the
appearance of those components in the Tris eluate. The proteins
are eluated roughly in proportion to the amount of hemoglobin
adhering to the membrane.
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removed both peripheral and integral membrane proteins. E and F represent the ghosts after membrane
bands 4.1 to 4.5, 5, 6, and 7, as well as the hemoglobin. It is suggested that the tightly adhering and
increased amounts of hemoglobin on diabetic membranes interfere with normal erythrocyte deformability because deformability is influenced by the peripheral proteins of the inner aspect of the red cell
membrane. Normal deformability is essential for normal blood flow since the diameter of erythrocytes is
greater than the diameter of the smallest blood vessels through which they must pass.
Finally there is evidence of disturbance in oxygen transport in diabetics. Rahbar 6 originally described the abnormal increases of the minor hemoglobin components Ala, b, and c in diabetic adults.
We have made a similar report in children. In spite of
acceptable control of their diabetes, young children,
and adults as well, have levels that are twice normal.
The important fact about hemoglobin Ale is that it
does not react with 2, 3 diphosphoglycerate (2,3
DPG), thus reducing the ability of hemoglobin Ale
to yield oxygen to the tissues. Opposing this impairment of oxygen release due to increased levels of Ale,
Ditzel has found elevated levels of 2,3 DPG but a
lower than normal P 50 • Phosphate administration to
these diabetic children brought their P50 to the level of
the normal control group. This may be a therapeutic
approach toward improving oxygenation of diabetic
tissue that warrants further study. 0
The legitimate question can now be raised as to
whether these intra vascular abnormalities are not due
solely to insulin ·deficiency and therefore simply reflect inadequate control of the diabetic state with
insulin. This may be true. At present we do not know.
However, in respect to the increases in acute phase
proteins observed in diabetics, studies of protein synthesis of the perfused rat liver by Miller have revealed
a very interesting finding. 7 Abnormal alpha cell function is an integral part of the diabetic state. 8 Glucagon secretion continues during periods of glucose
plenty and is stimulated by amino acids in the pressure of hyperglycemia. Miller has found that glucagon, either alone or in combination with cortisol,
stimulates the acute phase proteins including fibrinogen. The in vitro effects can be abolished with insulin.

The possibility thus arises that glucagon excess in a
setting of insulin deficiency is the initiating factor of
the sequence of events leading to microvascular occlusion. We have begun a prospective study in our
young diabetics of the degree of abnormality of
glucagon secretion and its progression, and the levels
of acute phase proteins, to determine if a correlation
exists between them.
I conclude by paraphrasing a well-known slogan, "We want to find a cure for diabetic microangiopathy before our diabetic children leave adolescence," because success of treatment undoubtedly lies
in applying it in the trouble-free childhood years.

The figure is reproduced with permission from Diabetes (25:

805-930,. 1976).
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